drugset

drugset / Trial / NCT05683470

Expanded Access RBS2418 Treatment

NCT05683470 ↗

Expanded access No longer available Riboscience, LLC. Dr. Bertrand Tuan · collab

Summary

This is an expanded access treatment protocol designed to provide access of RBS2418 to a single patient with pancreatic cancer.

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	RBS2418	Small molecule	200 mg	Oral

Indications

No indication recorded.